Cancer Drug Parity Act of 2025

[Congressional Bills 119th Congress] [From the U.S. Government Publishing Office] [H.R. 4101 Introduced in House (IH)] <DOC> 119th CONGRESS 1st Session H. R. 4101 To amend the Employee Retirement Income Security Act of 1974 to require a group health plan (or health insurance coverage offered in connection with such a plan) to provide for cost-sharing for oral anticancer drugs on terms no less favorable than the cost-sharing provided for anticancer medications administered by a health care provider. _______________________________________________________________________ IN THE HOUSE OF REPRESENTATIVES June 24, 2025 Mr. Grothman (for himself, Ms. Bonamici, Mr. Bilirakis, Mr. Fitzpatrick, Mr. Morelle, Ms. Matsui, Ms. Brownley, Ms. Moore of Wisconsin, Mr. Davis of North Carolina, Ms. Davids of Kansas, and Mr. Wilson of South Carolina) introduced the following bill; which was referred to the Committee on Education and Workforce _______________________________________________________________________ A BILL To amend the Employee Retirement Income Security Act of 1974 to require a group health plan (or health insurance coverage offered in connection with such a plan) to provide for cost-sharing for oral anticancer drugs on terms no less favorable than the cost-sharing provided for anticancer medications administered by a health care provider. Be it enacted by the Senate and House of Representatives of the United States of America in Congress assembled, SECTION 1. SHORT TITLE. This Act may be cited as the ``Cancer Drug Parity Act of 2025''. SEC. 2. PARITY IN COST-SHARING FOR ORAL ANTICANCER DRUGS. (a) In General.--The Employee Retirement Income Security Act of 1974 is amended by inserting after section 725 of such Act (29 U.S.C. 1185d) the following new section: ``SEC. 726. PARITY IN COST-SHARING FOR ORAL ANTICANCER DRUGS. ``(a) In General.--Subject to subsection (b), a group health plan (or health insurance coverage offered in connection with such a plan) that provides bene